This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
stock-price-movement: Archive
CoreCard (CCRD) Surges 10.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
CoreCard (CCRD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CCRDNegative Net Change ALLTNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Viant (DSP) Moves 7.2% Higher: Will This Strength Last?
by Zacks Equity Research
Viant (DSP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
DSPNegative Net Change DUOLNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Hudson Tech (HDSN) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Hudson Tech (HDSN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
HDSNPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Spok (SPOK) Rating Upgrade to Buy
by Zacks Equity Research
Spok (SPOK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SPOKPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About TowneBank (TOWN) Rating Upgrade to Buy
by Zacks Equity Research
TowneBank (TOWN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TOWNNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Meta Platforms (META) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Meta Platforms (META) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
METANegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes LATAM (LTM) a New Strong Buy Stock
by Zacks Equity Research
LATAM (LTM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
LTMNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Colony Credit (BRSP) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Colony Credit (BRSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BRSPNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Apollo Commerical Finance (ARI) Rating Upgrade to Strong Buy
by Zacks Equity Research
Apollo Commerical Finance (ARI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ARIPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Nextracker (NXT) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Nextracker (NXT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
NXTNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Coupang (CPNG) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Coupang (CPNG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
CPNGNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes Tenable (TENB) a New Buy Stock
by Zacks Equity Research
Tenable (TENB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TENBNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
After Golden Cross, Invesco (IVZ)'s Technical Outlook is Bright
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
IVZNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Bears are Losing Control Over Futu Holdings (FUTU), Here's Why It's a 'Buy' Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Futu Holdings (FUTU), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
FUTUNegative Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
CNB (CCNE) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for CNB (CCNE), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
CCNENegative Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Check Point (CHKP) Loses 16.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Check Point (CHKP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CHKPPositive Net Change
rsi stock-price-movement
Align Technology (ALGN) Loses 34.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ALGNPositive Net Change
rsi stock-price-movement
Down 7.1% in 4 Weeks, Here's Why Adtalem (ATGE) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Adtalem (ATGE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ATGEPositive Net Change
rsi stock-price-movement
After Plunging 15.4% in 4 Weeks, Here's Why the Trend Might Reverse for Gartner (IT)
by Zacks Equity Research
The heavy selling pressure might have exhausted for Gartner (IT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ITNegative Net Change
rsi stock-price-movement
Insight Enterprises (NSIT) Loses 17.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Insight Enterprises (NSIT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
NSITPositive Net Change
rsi stock-price-movement
DXP Enterprises (DXPE) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
DXP Enterprises (DXPE) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
DXPENegative Net Change
price-performance stock-price-change stock-price-movement
Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going
by Zacks Equity Research
Kiniksa Pharmaceuticals International, plc (KNSA) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
KNSAPositive Net Change
price-performance stock-price-change stock-price-movement
What Makes Spok (SPOK) a Good Fit for 'Trend Investing'
by Zacks Equity Research
Spok (SPOK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
SPOKPositive Net Change
price-performance stock-price-change stock-price-movement
SELLAS Life Sciences Group (SLS) Upgraded to Buy: What Does It Mean for the Stock? (Revised)
by Zacks Equity Research
SELLAS Life Sciences Group (SLS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
SLSPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Genius Sports Limited (GENI) Moves 10.6% Higher: Will This Strength Last?
by Zacks Equity Research
Genius Sports Limited (GENI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
GENIPositive Net Change YELPNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today